Equity and Innovation in Multidisciplinary Lung Cancer Care
The TOGA 2021 ASM will provide an opportunity for our multidisciplinary membership to come together to learn of advances in quality thoracic cancer care, to discuss their application in the local healthcare environment and to develop cross-cutting research capacity.
The two-day meeting program will include lung cancer screening, neoadjuvant treatment, the future influence of biomarker-driven treatments for lung cancer, the challenges of overcoming inequities in quality care, thought-provoking multi-disciplinary discussion, innovative clinical research and clinical trial concept development workshops.
Oral abstract and virtual post sessions will provide an opportunity for members to present their research, the conference dinner will celebrate the launch of TOGA, and a membership meeting will enable progress since TOGA was established to be outlined and invite members to engage with the TOGA leadership.